Related Experiment Video
Updated: Dec 7, 2025

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
Methylprednisolone pulse therapy: An alternative management of severe COVID-19
Patricia Merab Sauñe1, Mayte Bryce-Alberti2, Arianna Sibila Portmann-Baracco2
1Facultad de Medicina, Universidad Privada San Juan Bautista, José Antonio Ave, 302-304, Chorrillos District, Lima, Peru.
Abstract:
We present two cases of severe COVID-19 that were rejected by medical institutions. The management of the disease was done at home with methylprednisolone (MP) pulse therapy for three days. This resulted in a favorable evolution and resolution of most symptoms. COVID-19 infection presents as asymptomatic disease, non-severe symptomatic disease, and severe respiratory inflammatory disease. The first two forms are dependent on viral response and a "cytokine storm" is responsible for the progression into severe disease. Glucocorticoids (GC) reduce inflammation by different mechanism depending of their concentration. Pulses lead to overall apoptosis of immune cells. Studies using pulse MP as treatment for SARS-CoV-1 showed clinical improvement and decreased incidence of ARDS compared with patients who received low dose steroid treatment. Inhibition of excessive inflammation through timely administration of GC in the early stage of inflammatory cytokine storm effectively prevents the occurrence of ARDS.
Insights
Severe COVID-19 cases managed at home with methylprednisolone (MP) pulse therapy showed favorable outcomes. This treatment effectively resolved symptoms, highlighting MP
Area of Science:
- Infectious Diseases
- Immunology
- Pharmacology
Background:
- COVID-19 presents with varying severity, from asymptomatic to severe respiratory disease.
- Severe COVID-19 progression is linked to a "cytokine storm," an excessive inflammatory response.
- Glucocorticoids (GC) modulate inflammation; high-dose pulse therapy can induce immune cell apoptosis.
Observation:
- Two severe COVID-19 cases, initially denied medical care, were managed at home.
- Treatment involved three-day methylprednisolone (MP) pulse therapy.
- Patients experienced favorable symptom evolution and resolution.
Findings:
- Home-based methylprednisolone pulse therapy demonstrated efficacy in severe COVID-19.
- This approach led to significant clinical improvement and symptom resolution.
- Findings suggest MP pulse therapy can mitigate the inflammatory cascade in severe COVID-19.
Implications:
- Timely GC administration, particularly MP pulse therapy, may prevent Acute Respiratory Distress Syndrome (ARDS).
- This treatment strategy offers a potential alternative for managing severe COVID-19, especially when institutional care is limited.
- Further research into GC pulse therapy for COVID-19-induced cytokine storms is warranted.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

